Transforming Growth Factor-Beta (TGF-?) has profound immunosuppressive effects on a variety of immune cells. Natural killer (NK) cells are large granular lymphocytes that constitute a vital component of the innate immune system. NK cells produce abundant interferon gamma (IFN-?) to enhance tumor cell recognition and destruction, and to clear viral infection, including herpes simplex oncolytic viruses (OVs) in glioblastoma (GBM) treatment. Due to its complexity, TGF-? signaling has not been fully characterized. It also remains to be determined whether TGF-? itself or TGF-? signaling can be modulated to control NK cell functions in order to better control tumor progression and to enhance OV therapeutic efficacy in GBM. We hypothesize that TGF-? signaling can be further elucidated and modulated in NK cells to better understand cancer progression and enhance cancer treatment. Our goal is to investigate the molecular basis of how TGF-? suppresses NK anti-tumor activity by identifying the elements directly involved in this process, and to study the potential to increase the signaling to improve NK anti-tumor activity, but to decrease NK activity by pre-TGF-? treatment in the context of OV therapy, where NK cells limit OV expansion and therapeutic efficacy. Our proposed studies have a great potential to advance GBM treatment and/or GBM prevention and make us understand more about tumor and virus recognition and destruction. We will test our hypothesis through three Aims: 1) To determine the molecular basis of transcriptional repression of NK cell function by TGF-?;2) Can we disrupt TGF-? signaling to increase immune responses, and, in turn, to control GBM progression in vivo? 3) To augment TGF-? signaling in NK cells to enhance OV therapy efficacy in GBM.

Public Health Relevance

Glioblastoma (GBM) is the most common and aggressive brain tumor in humans. Although we have researched it for decades, survival time of patients suffering from GBM remains extremely poor. In this application, our first goal is to understand a very important negative signaling initiated by a cytokine, TGF-?. The other goal of this application is to either inhibit or enhance this signaling especially in NK cells at different contexts to treat GBM using our excellent animal models. Eventually, our long-term goal is to apply these studies in patients when we prove they are effective and safe.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA155521-01A1
Application #
8373667
Study Section
Transplantation, Tolerance, and Tumor Immunology (TTT)
Program Officer
Welch, Anthony R
Project Start
2012-09-21
Project End
2015-08-31
Budget Start
2012-09-21
Budget End
2013-08-31
Support Year
1
Fiscal Year
2012
Total Cost
$316,437
Indirect Cost
$108,937
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Teng, Kun-Yu; Han, Jianfeng; Zhang, Xiaoli et al. (2017) Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model. Mol Cancer Ther 16:312-322
Dai, Hong-Sheng; Griffin, Nathaniel; Bolyard, Chelsea et al. (2017) The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells. Immunity 47:159-170.e10
Chen, L; Mao, H; Zhang, J et al. (2017) Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia. Leukemia 31:1830-1834
Chen, Luxi; Yu, Jianhua (2016) Modulation of Toll-like receptor signaling in innate immunity by natural products. Int Immunopharmacol 37:65-70
Zhao, Shuting; Zhang, Lingling; Han, Jianfeng et al. (2016) Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia Activity. ACS Nano 10:6189-200
Han, Jianfeng; Chen, Xilin; Chu, Jianhong et al. (2015) TGF? Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response. Cancer Res 75:5273-82
Han, Jianfeng; Alvarez-Breckenridge, Christopher A; Wang, Qi-En et al. (2015) TGF-? signaling and its targeting for glioma treatment. Am J Cancer Res 5:945-55
Deng, Youcai; Kerdiles, Yann; Chu, Jianhong et al. (2015) Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function. Immunity 42:457-70
Zhao, Ran; Cui, Tiantian; Han, Chunhua et al. (2015) DDB2 modulates TGF-? signal transduction in human ovarian cancer cells by downregulating NEDD4L. Nucleic Acids Res 43:7838-49
Ren, Yulin; Yuan, Chunhua; Deng, Youcai et al. (2015) Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensis. Phytochemistry 111:132-40

Showing the most recent 10 out of 32 publications